CSI Market
Sign In | Register

180 Life Sciences (ATNF) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATNF Annual Balance Sheets →
Tracking balance sheet results across 180 Life Sciences to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent4.10
Marketable Securities43.97
Cash & Short-term Investments47.00
Accounts receivable1.02
Notes, Loans and Financing Receivable, Net, Current AC2.94
Disposal Group, Including Discontinued Operation, Assets, Current AS0.34
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.79
Total Current Assets14.19
Equipment/Property/Plant Net17.61
Intangible Assets0.00
Long-term investments43.97
Accounts Receivable, Net, Noncurrent14.27
Interest Receivable, Noncurrent0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent24.03
Total Assets159.03
Liabilities
Accounts Payable0.57
Accrued Liabilities, Current AC4.35
Collateralized Financings LI10.00
Loans Payable, Current NO2.94
Other Liabilities, Current0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.36
Total Current Liabilities5.28
Long-term debt17.21
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt17.21
Derivative Liability, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Discontinued Operation, Noncurrent0.36
Other liabilities, Noncurrent5.45
Operating Lease Liability Current0.90
Total Liabilities31.23
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value0.00
Additional Paid In Capital Common Stock812.12
Retained Earnings / Accumulated Deficit-681.13
Accumulated Other Comprehensive Income-3.18
Other Equity-3.18
Common Stockholder's Equity127.80
Non-controlling interests & other0.00
Total Stockholder's Equity127.80
Liabilities & Stockholder's Equity159.03
4 historic quarters locked

Sign in to unlock the full 180 Life Sciences balance sheet history.

Sign In Create Free Account

About Forum Markets Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-090100

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.